RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.Abstract Background Gonadotropin releasing hormone (GNRH1) triggers the release of follicle stimulating hormone and luteinizing hormone from the pituitary. Genetic variants in the gene encoding GNRH1 or its receptor may influence breast cancer risk by modulating production ...
Abstract: Background: Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor (GH...
Introduction: The female sex steroids estrogen and progesterone are important in breast cancer etiol...
Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number o...
Background Gonadotropin releasing hormone (GNRH1) triggers the release of follicle stimulating horm...
International audienceBACKGROUND: Gonadotropin releasing hormone (GNRH1) triggers the release of fol...
Introduction: Androgens have been hypothesised to influence risk of breast cancer through several ...
Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs...
Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs...
Purpose: This study aimed to assess whether haplotypes in XRCC1 and SNPs in OGG1 and XRCC3 were asso...
Background: Growth hormone (GH) SNPs are associated with breast cancer and colon cancer. The author ...
This study aimed to assess whether haplotypes in XRCC1 and SNPs in OGG1 and XRCC3 were associated wi...
as genetic risk factors for breast cancer. (rs2298735 and rs148972953) in both tumour and blood sam...
Contains fulltext : 89415.pdf (publisher's version ) (Closed access)Recent studies...
Association studies on susceptibility to breast cancer using single nucleotide polymorphisms (SNP) i...
ObjectiveOvarian cancer is a hormone-related disease with a strong genetic basis. However, none of i...
Abstract: Background: Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor (GH...
Introduction: The female sex steroids estrogen and progesterone are important in breast cancer etiol...
Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number o...
Background Gonadotropin releasing hormone (GNRH1) triggers the release of follicle stimulating horm...
International audienceBACKGROUND: Gonadotropin releasing hormone (GNRH1) triggers the release of fol...
Introduction: Androgens have been hypothesised to influence risk of breast cancer through several ...
Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs...
Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs...
Purpose: This study aimed to assess whether haplotypes in XRCC1 and SNPs in OGG1 and XRCC3 were asso...
Background: Growth hormone (GH) SNPs are associated with breast cancer and colon cancer. The author ...
This study aimed to assess whether haplotypes in XRCC1 and SNPs in OGG1 and XRCC3 were associated wi...
as genetic risk factors for breast cancer. (rs2298735 and rs148972953) in both tumour and blood sam...
Contains fulltext : 89415.pdf (publisher's version ) (Closed access)Recent studies...
Association studies on susceptibility to breast cancer using single nucleotide polymorphisms (SNP) i...
ObjectiveOvarian cancer is a hormone-related disease with a strong genetic basis. However, none of i...
Abstract: Background: Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor (GH...
Introduction: The female sex steroids estrogen and progesterone are important in breast cancer etiol...
Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number o...